Alector (NASDAQ:ALEC) used a presentation at the 46th Annual TD Cowen Healthcare Conference to highlight progress on its Alector Brain Carrier (ABC) platform, which is designed to deliver multiple ...

While the genus antibody claim was effectively killed by the U.S. Supreme Court in Amgen v. Sanofi, it lives on in Europe despite a few recent setbacks at the European Patent Office ("EPO") and the ...

ROSEMONT, Ill.--(BUSINESS WIRE)--Proteintech, a global leader in antibodies and life science solutions, is excited to announce additional product characterization for primary antibody targets on its ...

In a paper, "Epitope editing enables targeted immunotherapy of acute myeloid leukaemia," published in Nature, researchers at the Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, ...

Scientists from Australia have recently deciphered the structural and molecular basis of T cell-mediated recognition of a dominant epitope on the spike protein of severe acute respiratory syndrome ...

In a recent study published in Scientific Reports, a group of researchers designed and evaluated a multi-epitope vaccine targeting the main outer membrane protein (MOMP) protein of Chlamydia ...

CAR-T cell therapies have been heralded as a game changer for blood cancers, but those therapies approved so far have been focused on a few subtypes of leukemia, lymphoma and myeloma. Now, a new ...

Antibodies are a major component of adaptive immunity against invading pathogens. In this presentation, we will describe an analytical approach to characterize the antigen-specific antibody repertoire ...

Vaccines have arguably saved more lives than any other medical breakthrough. However, despite the long list of diseases that can now be controlled by vaccination, there are still some urgent unmet ...